Nuvation Bio Inc. Earnings Dividend

Nuvation Bio Inc.’s revenue jumped 2598.7% since last year same period to $83.23Mn in the Q1 2026. On a quarterly growth basis, Nuvation Bio Inc. has generated 98.8% jump in its revenue since last 3-months.

Nuvation Bio Inc.’s net profit jumped 110.14% since last year same period to $5.4Mn in the Q1 2026. On a quarterly growth basis, Nuvation Bio Inc. has generated 114.75% jump in its net profits since last 3-months.

Nuvation Bio Inc.’s net profit margin jumped 100.38% since last year same period to 6.48% in the Q1 2026. On a quarterly growth basis, Nuvation Bio Inc. has generated 107.42% jump in its net profit margins since last 3-months.

Nuvation Bio Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.15 - a -247.22% fall from last quarter’s estimates.

Nuvation Bio Inc.’s earning per share (EPS) estimates for the current year stand at -0.15.

Nuvation Bio Inc.’s earning per share (EPS) jumped 128.51% since last year same period to 0.04 in the Q1 2026. This indicates that the Nuvation Bio Inc. has generated 128.51% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Nuvation Bio Inc.’s return on assets (ROA) stands at -0.17.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Nuvation Bio Inc.’s return on equity (ROE) stands at -0.4.